Pedro Lichtinger
Chairman & CEO,
Starton Therapeutics
United States
Pedro Lichtinger is an industry executive with a 37-year career in biotechnology and a proven track record of developing turnaround and financing strategies, executing strategic alliances, and building commercial and R&D capabilities.
He is the former President of Global Primary Care and President of Europe at Pfizer Inc with 16 years’ experience, and the former CEO of Asterias Biotherapeutics and Optimer Pharmaceuticals.
He currently sits on the Advisory Board of Zero Gravity. He holds an MBA degree from Wharton School of Business and an engineering degree from the National University of Mexico.
Sessions
-
27-Feb-2024Starton Therapeutics
)
){kind=logo}
)
){kind=logo}
){kind=logo}